{
  "cik": 1818794,
  "cik_padded": "0001818794",
  "entityName": "Dyne Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-084178",
      "filed": "2026-03-02",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1920000.0,
        "cash": 893369000.0,
        "eps_diluted": -3.47,
        "free_cash_flow": -405127000.0,
        "net_income": -446214000.0,
        "operating_cash_flow": -403207000.0,
        "operating_income": -468184000.0,
        "stockholders_equity": 972129000.0,
        "total_assets": 1186958000.0,
        "total_liabilities": 214829000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.22098816103624108,
        "roa_avg2y": -0.47515270004344606,
        "roa_period_end": -0.37593074059907766,
        "roe_avg2y": -0.5570826365337114,
        "roe_period_end": -0.45900698364105996
      }
    },
    {
      "accn": "0001193125-26-084178",
      "filed": "2026-03-02",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2376000.0,
        "cash": 435449000.0,
        "eps_diluted": -3.37,
        "free_cash_flow": -294745000.0,
        "net_income": -317418000.0,
        "operating_cash_flow": -292369000.0,
        "operating_income": -343886000.0,
        "stockholders_equity": 629838000.0,
        "total_assets": 691234000.0,
        "total_liabilities": 61396000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09747903429135746,
        "roa_avg2y": -0.7413571625427996,
        "roa_period_end": -0.45920484235439807,
        "roe_avg2y": -0.8803350297449836,
        "roe_period_end": -0.5039676869290198
      }
    },
    {
      "accn": "0001193125-26-084178",
      "filed": "2026-03-02",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 729000.0,
        "cash": 121626000.0,
        "eps_diluted": -3.95,
        "free_cash_flow": -188887000.0,
        "net_income": -235937000.0,
        "operating_cash_flow": -188158000.0,
        "operating_income": -242162000.0,
        "stockholders_equity": 91292000.0,
        "total_assets": 165082000.0,
        "total_liabilities": 73790000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.8082855014678175,
        "roa_avg2y": -1.000990651390412,
        "roa_period_end": -1.42921093759465,
        "roe_avg2y": -1.3730998440300766,
        "roe_period_end": -2.5844214169916313
      }
    },
    {
      "accn": "0001193125-26-084178",
      "filed": "2026-03-02",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3067000.0,
        "cash": 172147000.0,
        "eps_diluted": -3.23,
        "free_cash_flow": -156712000.0,
        "net_income": -168099000.0,
        "operating_cash_flow": -153645000.0,
        "operating_income": -170962000.0,
        "stockholders_equity": 252364000.0,
        "total_assets": 306325000.0,
        "total_liabilities": 53961000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.21382209823905152,
        "roa_avg2y": -0.45929441466253546,
        "roa_period_end": -0.5487603035991185,
        "roe_avg2y": -0.5417646291017322,
        "roe_period_end": -0.666097383144981
      }
    },
    {
      "accn": "0000950170-25-028356",
      "filed": "2025-02-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3618000.0,
        "cash": 200825000.0,
        "eps_diluted": -2.93,
        "free_cash_flow": -123181000.0,
        "net_income": -149291000.0,
        "operating_cash_flow": -119563000.0,
        "operating_income": -150025000.0,
        "stockholders_equity": 368197000.0,
        "total_assets": 425663000.0,
        "total_liabilities": 57466000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.15607405818081083,
        "roa_avg2y": -0.38329030792159663,
        "roa_period_end": -0.35072580891456384,
        "roe_avg2y": -0.42020423213109587,
        "roe_period_end": -0.40546500922060746
      }
    },
    {
      "accn": "0000950170-23-005708",
      "filed": "2023-03-02",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1161000.0,
        "cash": 300852000.0,
        "free_cash_flow": -47669000.0,
        "net_income": -59437000.0,
        "operating_cash_flow": -46508000.0,
        "operating_income": -58647000.0,
        "stockholders_equity": 342367000.0,
        "total_assets": 353334000.0,
        "total_liabilities": 10967000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.03203287700041184,
        "roa_avg2y": -0.3214809205722476,
        "roa_period_end": -0.1682176071365903,
        "roe_avg2y": -0.3335381576473823,
        "roe_period_end": -0.17360610105530033
      }
    },
    {
      "accn": "0001564590-21-010726",
      "filed": "2022-03-10",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1647000.0,
        "cash": 14632000.0,
        "free_cash_flow": -13481000.0,
        "net_income": -14859000.0,
        "operating_cash_flow": -11834000.0,
        "operating_income": -13826000.0,
        "stockholders_equity": 14036000.0,
        "total_assets": 16436000.0,
        "total_liabilities": 2400000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.17098888572242804,
        "roa_period_end": -0.9040520807982477,
        "roe_avg2y": -3.2453860434640167,
        "roe_period_end": -1.0586349387289826
      }
    },
    {
      "accn": "0001564590-21-010726",
      "filed": "2021-03-04",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -4879000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-084178",
    "filed": "2026-03-02",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001818794.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001818794.json"
  },
  "ticker": "DYN"
}